BRAF and thyroid gland carcinoma: Even if, activation of NOTCH pathway has been shown to restrain thyroid cancer cell proliferation22, NOTCH1 expression is upregulated in thyroid cancers with BRAF, RET/PTC mutations, or active MAPK signaling.